MichaelBDattoMD

Pathology • Durham, NC

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, Duke University School of Medicine

Join to view full profile

Are you Dr. Datto?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
Duke Medical Ctr
Durham, NC 27710
Phone+1 919-620-4467

Summary

Dr. Michael Datto, MD is a board certified pathologist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with Duke University Hospital and Duke Regional Hospital.

Education & Training

Duke University HospitalResidency, Pathology-Anatomic and Clinical, 2000 - 2004
Duke University School of MedicineClass of 1999

Certifications & Licensure

NC State Medical License 2000 - 2025
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States.
Anivarya Kumar, Jennifer R Owen, Nicholette T Sloat, Elizabeth Maynard, Vanessa M Hill
Current Oncology. 2024-11-16
Addressing False Positives in High-Sensitivity Troponin I Testing: Mitigation Strategies.
Ruhan Wei, Bruce Lobaugh, Donna Kirsch, Jieli Li, Michael Datto
The Journal of Applied Laboratory Medicine. 2024-11-04
Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice.
Chenyu Lin, Katherine I Zhou, Michelle F Green, Bennett A Caughey, John H Strickler
Hematology Reports. 2024-09-30

Press Mentions

Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health SystemJune 15th, 2021
Real World Utilization of the Myositis Autoantibody PanelFebruary 24th, 2021
Schools Try New COVID-19 Testing Strategy: Pooling SpecimensFebruary 8th, 2021
Join now to see all